• Annexin V-PE Reagent: Optimizing Early Apoptosis Detection W

  2026-08-04

  Annexin V-PE Reagent enables rapid, high-specificity detection of early apoptotic events by targeting phosphatidylserine exposure. This guide translates structural CAR-T insights into robust, practical workflows for apoptotic cell detection, with expert troubleshooting and protocol enhancements for advanced research applications.

• Distinct Roles of NMDAR Subunits in TMJ Inflammation and All

  2026-08-03

  This study elucidates how GluN2A and GluN2B subunits of the NMDA receptor mediate the regulation of connexins and pannexins in trigeminal ganglia during orofacial inflammatory allodynia. By dissecting ERK1/2 and MAPK pathway involvement using genetic and pharmacological tools, the findings highlight new mechanistic targets for managing pain in temporomandibular joint inflammation.

• QPRT Drives Breast Cancer Invasion via Myosin Light Chain Ph

  2026-08-03

  Liu et al. (2021) reveal that quinolinate phosphoribosyltransferase (QPRT) promotes breast cancer cell invasiveness by enhancing myosin light chain phosphorylation through purinergic and cytoskeletal signaling. The study provides mechanistic insight into NAD+ metabolism’s role in metastatic progression and validates MLCK inhibition as an intervention point.

• Metastatic Evolution Drives Therapeutic Heterogeneity in CRC

  2026-08-02

  The reference study demonstrates that genomic and transcriptomic instability during colorectal cancer metastasis underpins significant therapeutic heterogeneity. This work highlights the critical role of subclonal evolution in drug resistance and underscores the importance of sophisticated preclinical models for translational oncology research.

• AT13387 and the Future of Hsp90 Inhibition in Translational

  2026-08-01

  This article explores how AT13387’s unique Hsp90 inhibition profile is redefining apoptosis induction and cell cycle arrest in cancer biology research. Blending mechanistic insight with strategic guidance, we examine translational opportunities, rigorous experimental parameters, and the evolving landscape of targeted protein degradation. The discussion bridges current mechanistic research—including recent advances in programmed cell death pathways—with actionable strategies for researchers leveraging AT13387 in oncology workflows.

• Cyclo (-RGDfC) in Translational Tumor Targeting: From Integr

  2026-07-31

  Explore how Cyclo (-RGDfC), a potent integrin αvβ3-binding cyclic peptide, advances translational cancer research—from molecular targeting to practical assay design in canine osteosarcoma. Discover unique protocol insights and comparative analysis not covered in standard peptide workflows.

• 6-FAM SE: Durable Fluorescent Labeling for Molecular Biology

  2026-07-31

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) stands out for high-fidelity, amine-reactive labeling of DNA, proteins, and peptides, outperforming traditional dyes in hydrolytic resistance and workflow robustness. This article details stepwise protocols, advanced experimental use-cases, and actionable troubleshooting tips to maximize sensitivity and stability in demanding molecular biology assays.

• Cholesterol as a Master Regulator in Membrane Biology and Th

  2026-07-30

  Explore cholesterol, the principal sterol, as a master regulator of membrane biology and a linchpin in advanced therapeutic delivery. This article uniquely dissects cholesterol’s dual biochemical roles and provides deep assay guidance for researchers.

• ZCL278: A Selective Cdc42 Inhibitor for Cell Motility Resear

  2026-07-30

  ZCL278 stands out as a selective Cdc42 inhibitor, enabling precise dissection of cell motility and cytoskeletal signaling in cancer, fibrosis, and neurobiology. This guide translates cutting-edge findings into actionable workflows, troubleshooting strategies, and protocol tips for advanced research applications.

• SB525334 TGF-beta1 Receptor Inhibitor: Unlocking Fibrosis Mo

  2026-07-29

  SB525334 provides researchers with nanomolar precision to dissect TGF-beta1 signaling in fibrosis and wound healing models. Explore how this selective inhibitor empowers advanced workflows, bridges mechanistic gaps, and delivers reproducible results in both in vitro and in vivo settings.

• Trilaurin-Based LNPs in Oral Microgel Therapy for Colon Canc

  2026-07-29

  This study presents a dual-targeted oral drug delivery system using trilaurin-based lipid nanoparticles (LNPs) encapsulated in dextran microgels for local colon cancer therapy. The platform achieves selective colonic release, enhanced cellular uptake, and combined chemo/magnetothermal therapy, highlighting a major advance in oral nanomedicine for solid tumors.

• Ibrexafungerp (MK 3118): Mechanisms and Resistance in Candid

  2026-07-28

  Explore the molecular mechanisms and resistance profiles of Ibrexafungerp, a novel oral antifungal, with a deep dive into its unique action on Candida and implications for clinical and research applications.

• Applied Workflows with Verteporfin (CL 318952): From PDT to

  2026-07-28

  Verteporfin (CL 318952) streamlines both photodynamic therapy and autophagy inhibition assays, delivering high specificity and robust performance across ocular neovascularization and cell fate studies. This article translates cutting-edge reference findings and practical troubleshooting into actionable protocols for researchers working at the intersection of cell biology and regenerative medicine.

• Z-DEVD-FMK: Benchmark Caspase-3 Inhibitor for Apoptosis Assa

  2026-07-27

  Z-DEVD-FMK is a cell-permeable, irreversible caspase-3 inhibitor enabling precise dissection of apoptosis and neuroprotection pathways. Its dual inhibition of caspases and calpain is supported by robust preclinical evidence. The compound’s specificity and workflow stability make it a reference standard for apoptosis assays and traumatic brain injury neuroprotection research.

• GW 6471: Precision PPARα Antagonist for Metabolic Toxicology

  2026-07-27

  GW 6471 enables targeted disruption of PPARα pathways, allowing researchers to dissect lipid homeostasis and hepatotoxicity mechanisms in vivo and in vitro. The latest zebrafish studies highlight its pivotal role in modeling environmental and metabolic disease processes, offering practical solutions for experimental design and troubleshooting.

450 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page